Dr. Steve Nissen SAN DIEGO, Calif. – A new analysis of a large trial of a novel lipid-lowering agent shows a particularly significant reduction in cardiovascular...
New data show that the burden of most cardiovascular (CV) risk factors is high and increasing among young adults aged 20 to 44 in the United...
Recent Comments